| Address: | 210 Bent St, Cambridge, MA 02141, USA |
|---|---|
| Postal code: | 02141 |
| Phone: | (617) 649-2001 |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Ore Pharmaceutical Holdings, use the form below and your opinion, advice or comment will appear in this space.
Ore Pharmaceutical Holdings asub kohas Cambridge (Massachusetts). Ore Pharmaceutical Holdings ei tegutse valdkondades Ostlemine, Apteegid ja narkootikumide kauplustes. Ettevõttega saate ühendust numbril (617) 649-2001. J. Stark Thompson on seotud selle ettevõttega.
Ore Pharmaceutical Holdings,inc has a registered NCAGE Code for doing business with international governments. UNITED STATES. Phone Contacts. 617-649-2008.
Ore pharmaceutical holdings, inc. Attention: Chairman of the Board. Ore Pharmaceutical Holdings Inc. One Main Street. Suite 300. Cambridge, MA 02142. Fax: 617-649-2050.
Home SEC Filings Ore Pharmaceutical Holdings Inc. (ORXE) 8-K Material Event Fri Sep 18 2009. 8-K Corporate News.
Ore Pharmaceutical Holdings Inc is primarely in the business of in vitro & in vivo diagnostic substances. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K...
Amended and Restated Bylaws of Ore Pharmaceuticals Inc.
Ore pharmaceutical holdings inc. Glgc. 4,540,687.
Ore Pharmaceutical Holdings Inc. CIK: 0001043914 Incorporation State: Delaware. FORMER NAMES GENE LOGIC INC through July 17, 2009 ORE PHARMACEUTICALS INC. through September 18, 2009.
Ore Holdings (formerly Ore Pharmaceutical Holdings) aimed to make its mark in the drug development business. The company was focused on helping drugmakers revive inactive development programs, working to identify potentially useful drugs that stalled during earlier development ...
Home > Insider Trading > Ore Pharmaceutical Holdings Inc. > Profile. Profile Hedge Fund Holdings Insider Purchases Insider Sales Other Institutional Investors' Holdings News.